Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan
Cervical Cancer IHC Antibodies
Cervical cancers are a relatively rare diagnosed cancer in the United States, with about 0.7% of new cancer cases classified as cervical, contributing approx. 0.7% of cancer deaths yearly. As of 2011, there were approximately 250,000 women living with cervical cancer in the United States. Those with cervical cancer have a 5 year survival rate of 67.9%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.2% and 1.3% per year, respectively. Biocare Medical is proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
List of Antibody: Antib0dy CD20, Antibody AMACR (RM), Antibody Androgen Receptor, Antibody Arginase-1, antibody c-erB-2 / HER2 , Antibody c-Myc, antibody Calponin , Antibody Catenin 14/Beta-Catenin, Antibody CD7, Antibody CDH17, Antibody Cytokeratin 5, Antibody Cytokeratin 7, Antibody Cytokeratin HMW, antibody e-cadherin, antibody ERG, Antibody Estrogen Receptor (ER), Antibody Folate Receptor alpha, Antibody GCDFP-15, Antibody Ki-67, Antibody Mammaglobin, antibody P40, antibody p53, Antibody p63, Antibody Phospho-Histone H3, Antibody Progesterone Receptor (PR), antibody PTEN, Antibody SOX11.